Status:
UNKNOWN
Efficacy of Surfactant and Perinatal Risk Factors in NRDS With Different Gestational Ages
Lead Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Conditions:
Infant, Newborn, NRDS
Eligibility:
All Genders
1-28 years
Brief Summary
Since exogenous surfactant replacement therapy was first used to prevent neonatal respiratory distress syndrome (NRDS)，it has become the main method of treatment of NRDS. However, in some infants, dea...
Eligibility Criteria
Inclusion
- Infants with RDS who received surfactant therapy were recruited between January 2011 and December 2016.
Exclusion
- Infants were excluded if they had any congeni- tal malformation, inherited metabolic abnormality, intrauterine infection, Rh/Rh incompatibility, pneumonia, pulmonary hypertension, meconium aspiration syndrome, or asphyxia.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2018
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT03385863
Start Date
January 1 2011
End Date
March 1 2018
Last Update
December 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of pediatrics, Daping Hospital, The Third Military Medical University
Chongqing, Chongqing Municipality, China, 400042